Placental microparticles, DNA, and RNA in preeclampsia

Hypertension in Pregnancy

Volumn 30, Issue 3, 2011, Pages 364-375

  Rusterholz, Corinne ^a   Messerli, Marianne ^a   Hoesli, Irene ^a   Hahn, Sinuhe ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Cell free fetal DNA; Feto maternal interactions; Placental microparticles; Preeclampsia; Pregnancy

Indexed keywords

DNA; RNA;

ENDOTHELIUM CELL; HUMAN; INNATE IMMUNITY; MEMBRANE MICROPARTICLE; PREECLAMPSIA; PREGNANCY; PROTEIN EXPRESSION; REPRODUCTION; REVIEW; SYNCYTIOTROPHOBLAST; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL-DERIVED MICROPARTICLES; DNA; FEMALE; HUMANS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RNA;

EID: 79960182326     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641951003599571     Document Type: Review

References (93)

1. Grill S, Rusterholz C, Zanetti-Dallenbach R, et al. Potential markers of preeclampsia-a review. Reprod Biol Endocrinol 2009; 7:70-83.
2. Audibert F. Screening for pre-eclampsia: the quest for the Holy Grail? Lancet 2005; 365:1367-1369. (Pubitemid 40523720)
3. Wen SW, Chen XK, Rodger M, et al. Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol 2008; 198:45-47.
4. Bucher HC, Guyatt GH, Cook RJ, et al. Effect of calcium supplementation on pregnancyinduced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA 1996; 275:1113-1117.
5. Coomarasamy A, Honest H, Papaioannou S, Gee H, Khan KS. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 2003; 101:1319-1332. (Pubitemid 36694362)
6. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006; 367:1145-1154.
7. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365:785-799. (Pubitemid 40311367)
8. Hahn S, Gupta AK, Troeger C, Rusterholz C, Holzgreve W. Disturbances in placental immunology: ready for therapeutic interventions? Springer Semin Immunopathol 2006; 27:477-493. (Pubitemid 43833129)
9. Jauniaux E, Poston L, Burton GJ. Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update 2006; 12:747-755. (Pubitemid 44605512)
10. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response-a review. Placenta 2003; 24(Suppl A):S21-S27. (Pubitemid 37184731)
11. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200-1204. (Pubitemid 20007682)
12. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180:499-506. (Pubitemid 29093892)
13. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008; 51:970-975. (Pubitemid 351398986)
14. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta 2009; 30(Suppl A):S32-S37.
15. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350:485-487. (Pubitemid 27343304)
16. Ariga H, Ohto H, Busch MP, et al. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion 2001; 41:1524-1530. (Pubitemid 34072677)
17. Rijnders RJ, Van Der Luijt RB, Peters ED, et al. Earliest gestational age for fetal sexing in cell-free maternal plasma. Prenat Diagn 2003; 23:1042-1044. (Pubitemid 38084143)
18. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999; 64:218-224. (Pubitemid 30428975)
19. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998; 62:768-775. (Pubitemid 28194317)
20. Hahn S, Chitty LS. Noninvasive prenatal diagnosis: current practice and future perspectives. Curr Opin Obstet Gynecol 2008; 20:146-151. (Pubitemid 351498766)
21. Hyett JA, Gardener G, Stojilkovic-Mikic T, et al. Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenat Diagn 2005; 25:1111-1116. (Pubitemid 43016291)
22. Legler TJ, Lynen R, Maas JH, et al. Prediction of fetal Rh D and Rh CcEe phenotype from maternal plasma with real-time polymerase chain reaction. Transfus Apher Sci 2002; 27:217-223. (Pubitemid 35341658)
23. Zhong XY, Holzgreve W, Hahn S. Detection of fetal Rhesus D and sex using fetal DNA from maternal plasma by multiplex polymerase chain reaction. BJOG 2000; 107:766-769. (Pubitemid 30311913)
24. Lo YM, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998; 339:1734-1738. (Pubitemid 28555431)
25. Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 2005; 293:843-849. (Pubitemid 40250368)
26. Li Y, Hahn S, Holzgreve W. Recent developments in the detection of fetal single gene differences in maternal plasma and the role of size fractionation. Ann N Y Acad Sci 2006; 1092:285-292. (Pubitemid 47092345)
27. Zhong XY, Holzgreve W, Hahn S. Cell-free fetal DNA in the maternal circulation does not stem from the transplacental passage of fetal erythroblasts. Mol Hum Reprod 2002; 8:864-870. (Pubitemid 35012475)
28. Masuzaki H, Miura K, Yoshiura KI, Yoshimura S, Niikawa N, Ishimaru T. Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism. J Med Genet 2004; 41:289-292. (Pubitemid 38496774)
29. Alberry M, Maddocks D, Jones M, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 2007; 27:415-418. (Pubitemid 47164339)
30. Hyodo M, Samura O, Miharu N, Ohama K, Kudo Y. Molar DNA in maternal serum in a case of 46,XY heterozygous complete hydatidiform mole coexisting with a 46,XX twin live fetus. Clin Chem 2005; 51:676-677. (Pubitemid 40300256)
31. Zhong XY, Burk MR, Troeger C, Jackson LR, Holzgreve W, Hahn S. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn 2000; 20:795-798.
32. Wataganara T, Bianchi DW. Fetal cell-free nucleic acids in the maternal circulation: new clinical applications. Ann N Y Acad Sci 2004; 1022:90-99. (Pubitemid 38951587)
33. Lee T, Leshane ES, Messerlian GM, et al. Down syndrome and cell-free fetal DNA in archived maternal serum. Am J Obstet Gynecol 2002; 187:1217-1221. (Pubitemid 35397462)
34. Caramelli E, Rizzo N, Concu M, et al. Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction-a pilot study. Prenat Diagn 2003; 23:367-371. (Pubitemid 36596963)
35. Al Nakib M, Desbriere R, Bonello N, et al. Total and fetal cell-free DNA analysis in maternal blood as markers of placental insufficiency in intrauterine growth restriction. Fetal Diagn Ther 2009; 26:24-28.
36. Farina A, Leshane ES, Romero R, et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2005; 193:421-425. (Pubitemid 41159536)
37. Lo YM, Leung TN, Tein MS, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999; 45:184-188. (Pubitemid 29079115)
38. Zhong XY, Laivuori H, Livingston JC, et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 2001; 184:414-419. (Pubitemid 32206993)
39. Zhong XY, Holzgreve W, Hahn S. Circulatory fetal and maternal DNA in pregnancies at risk and those affected by preeclampsia. Ann N Y Acad Sci 2001; 945:138-140. (Pubitemid 33022442)
40. Smid M, Vassallo A, Lagona F, et al. Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities. Ann N Y Acad Sci 2001; 945:132-137. (Pubitemid 33022441)
41. Zhong XY, Gebhardt S, Hillermann R, Tofa KC, Holzgreve W, Hahn S. Parallel assessment of circulatory fetal DNA and corticotropin-releasing hormone mRNA in early- and late-onset preeclampsia. Clin Chem 2005; 51:1730-1733. (Pubitemid 41233115)
42. Swinkels DW, de Kok JB, Hendriks JC, Wiegerinck E, Zusterzeel PL, Steegers EA. Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem 2002; 48:650-653. (Pubitemid 34261231)
43. Sekizawa A, Jimbo M, Saito H, et al. Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol 2003; 188:480-484. (Pubitemid 36249989)
44. Leung TN, Zhang J, Lau TK, Chan LY, Lo YM. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 2001; 47:137-139. (Pubitemid 32064290)
45. Zhong XY, Holzgreve W, Hahn S. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy 2002; 21:77-83. (Pubitemid 34437747)
46. Farina A, Sekizawa A, Sugito Y, et al. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. Prenat Diagn 2004; 24:83-86. (Pubitemid 38294411)
47. Sifakis S, Zaravinos A, Maiz N, Spandidos DA, Nicolaides KH. First-trimester maternal plasma cell-free fetal DNA and preeclampsia. Am J Obstet Gynecol 2009; 201:472-477.
48. Illanes S, Parra M, Serra R, et al. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction. Prenat Diagn 2009; 29:1118-1122.
49. Levine RJ, Qian C, Leshane ES, et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004; 190:707-713. (Pubitemid 38406782)
50. Chan KC, Zhang J, Hui AB, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004; 50:88-92. (Pubitemid 38125703)
51. Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgreve W, Hahn S. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 2004; 50:1002-1011. (Pubitemid 38725787)
52. Lui YY, Chik KW, Chiu RW, Ho CY, Lam CW, Lo YM. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 2002; 48:421-427. (Pubitemid 34174575)
53. Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, Burton GJ. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol 2006; 169:400-404. (Pubitemid 44156302)
54. Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin Chem 2000; 46:1832-1834.
55. Ng EK, Tsui NB, Lau TK, et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci U S A 2003; 100:4748-4753. (Pubitemid 36457801)
56. Ng EK, Tsui NB, Lam NY, et al. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem 2002; 48:1212-1217. (Pubitemid 34809828)
57. Rusterholz C, Holzgreve W, Hahn S. Oxidative stress alters the integrity of cell-free mRNA fragments associated with placenta-derived syncytiotrophoblast microparticles. Fetal Diagn Ther 2007; 22:313-317. (Pubitemid 46920094)
58. Ng EK, Leung TN, Tsui NB, et al. The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin Chem 2003; 49:727-731. (Pubitemid 36513250)
59. Purwosunu Y, Sekizawa A, Farina A, et al. Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia. Prenat Diagn 2007; 27:772-777. (Pubitemid 47242409)
60. Purwosunu Y, Sekizawa A, Koide K, et al. Cell-free mRNA concentrations of plasminogen activator inhibitor-1 and tissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia. Clin Chem 2007; 53:399-404. (Pubitemid 46447935)
61. Reimer T, Koczan D, Gerber B, Richter D, Thiesen HJ, Friese K. Microarray analysis of differentially expressed genes in placental tissue of pre-eclampsia: up-regulation of obesity-related genes. Mol Hum Reprod 2002; 8:674-680. (Pubitemid 34752929)
62. Hansson SR, Chen Y, Brodszki J, et al. Gene expression profiling of human placentas from preeclamptic and normotensive pregnancies. Mol Hum Reprod 2006; 12:169-179.
63. Huppertz B, Kadyrov M, Kingdom JC. Apoptosis and its role in the trophoblast. Am J Obstet Gynecol 2006; 195:29-39. (Pubitemid 43927489)
64. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002; 186:158-166. (Pubitemid 34093758)
65. Huppertz B, Kingdom J, Caniggia I, et al. Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta 2003; 24:181-190. (Pubitemid 37184714)
66. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membranederived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20:1487-1495. (Pubitemid 44264090)
67. Diamant M, Tushuizen ME, Sturk A, Nieuwland R. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004; 34:392-401. (Pubitemid 38859560)
68. VanWijk MJ, Nieuwland R, Boer K, van der Post JA, Vanbavel E, Sturk A. Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction? Am J Obstet Gynecol 2002; 187:450-456. (Pubitemid 34925587)
69. Knight M, Redman CW, Linton EA, Sargent IL. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol 1998; 105:632-640. (Pubitemid 28293481)
70. Goswami D, Tannetta DS, Magee LA, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 2006; 27:56-61. (Pubitemid 41662880)
71. Lok CA, van der Post JA, Sargent IL, et al. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens Pregnancy 2008; 27:344-360.
72. Smith NC, Brush MG, Luckett S. Preparation of human placental villous surface membrane. Nature 1974; 252:302-303.
73. Rusterholz C, Gupta AK, Huppertz B, Holzgreve W, Hahn S. Soluble factors released by placental villous tissue: Interleukin-1 is a potential mediator of endothelial dysfunction. Am J Obstet Gynecol 2005; 192:618-624. (Pubitemid 40215005)
74. Di Santo S, Sager R, Andres AC, Guller S, Schneider H. Dual in vitro perfusion of an isolated cotyledon as a model to study the implication of changes in the third trimester placenta on preeclampsia. Placenta 2007; 28(Suppl A):S23-S32. (Pubitemid 46506054)
75. Smarason AK, Sargent IL, Starkey PM, Redman CW. The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol 1993; 100:943-949. (Pubitemid 23308283)
76. Cockell AP, Learmont JG, Smarason AK, Redman CW, Sargent IL, Poston L. Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol 1997; 104:235-240. (Pubitemid 27065151)
77. Gupta AK, Rusterholz C, Huppertz B, et al. A comparative study of the effect of three different syncytiotrophoblast micro-particles preparations on endothelial cells. Placenta 2005; 26:59-66. (Pubitemid 40123677)
78. Gupta AK, Holzgreve W, Hahn S. Decrease in lipid levels of syncytiotrophoblast micro-particles reduced their potential to inhibit endothelial cell proliferation. Arch Gynecol Obstet 2008; 277:115-119. (Pubitemid 350308022)
79. Lok CA, Boing AN, Reitsma PH, et al. Expression of inflammation-related genes in endothelial cells is not directly affected by microparticles from preeclamptic patients. J Lab Clin Med 2006; 147:310-320. (Pubitemid 43794916)
80. Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179:80-86. (Pubitemid 28394477)
81. Holthe MR, Staff AC, Berge LN, Lyberg T. Leukocyte adhesion molecules and reactive oxygen species in preeclampsia. Obstet Gynecol 2004; 103:913-922. (Pubitemid 40458992)
82. Aly AS, Khandelwal M, Zhao J, Mehmet AH, Sammel MD, Parry S. Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to generate superoxide radicals in women with preeclampsia. Am J Obstet Gynecol 2004; 190:252-258. (Pubitemid 38156356)
83. Gupta AK, Hasler P, Holzgreve W, Gebhardt S, Hahn S. Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. Hum Immunol 2005; 66:1146-1154.
84. Brinkmann V, Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol 2007; 5:577-582. (Pubitemid 47074113)
85. Gupta AK, Hasler P, Holzgreve W, Hahn S. Neutrophil NETs: a novel contributor to preeclampsia- associated placental hypoxia? Semin Immunopathol 2007; 29:163-167. (Pubitemid 47596396)
86. Gupta A, Hasler P, Gebhardt S, Holzgreve W, Hahn S. Occurrence of neutrophil extracellular DNA traps (NETs) in pre-eclampsia: a link with elevated levels of cell-free DNA? Ann N Y Acad Sci 2006; 1075:118-122. (Pubitemid 44532773)
87. Koumandakis E, Koumandaki I, Kaklamani E, Sparos L, Aravantinos D, Trichopoulos D. Enhanced phagocytosis of mononuclear phagocytes in pregnancy. Br J Obstet Gynaecol 1986; 93:1150-1154. (Pubitemid 17179945)
88. Shibuya T, Izuchi K, Kuroiwa A, Okabe N, Shirakawa K. Study on nonspecific immunity in pregnant women: increased chemiluminescence response of peripheral blood phagocytes. Am J Reprod Immunol Microbiol 1987; 15:19-23. (Pubitemid 18005741)
89. Luppi P, Haluszczak C, Betters D, Richard CA, Trucco M, Deloia JA. Monocytes are progressively activated in the circulation of pregnant women. J Leukoc Biol 2002; 72:874-884. (Pubitemid 35365161)
90. Sacks GP, Redman CW, Sargent IL. Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin Exp Immunol 2003; 131:490-497. (Pubitemid 36324141)
91. Luppi P, Deloia JA. Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol 2006; 118:268-275. (Pubitemid 43199666)
92. Messerli M, May K, Hansson SR, et al. Feto-maternal interactions in pregnancies: Placental microparticles activate peripheral blood monocytes. Placenta 2010; 31:106-112.
93. Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007; 178:5949-5956. (Pubitemid 46674392)